Research programme: G protein-coupled receptor modulators - Domain Therapeutics/Ono Pharmaceutical
Latest Information Update: 16 Jul 2016
Price :
$50 *
At a glance
- Originator Domain Therapeutics; Ono Pharmaceutical
- Class Small molecules
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Undefined in France
- 23 Oct 2012 Early research in Undefined indication in France (unspecified route)